Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS)
CNY 19.25
(-3.12%)
CNY 19.25
(-3.12%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 265.56 Million CNY | 24.35% |
| 2022 | 213.56 Million CNY | 0.16% |
| 2021 | 213.22 Million CNY | 14.64% |
| 2020 | 185.99 Million CNY | 23.27% |
| 2019 | 150.87 Million CNY | -10.66% |
| 2018 | 168.87 Million CNY | 45.23% |
| 2017 | 116.28 Million CNY | 41.91% |
| 2016 | 81.93 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 364.64 Million CNY | 16.01% |
| 2024 Q2 | 314.32 Million CNY | 2.44% |
| 2024 Q1 | 306.84 Million CNY | 15.55% |
| 2023 Q3 | 308.53 Million CNY | -0.19% |
| 2023 Q2 | 309.11 Million CNY | -2.21% |
| 2023 FY | 265.56 Million CNY | 24.35% |
| 2023 Q1 | 316.1 Million CNY | 48.02% |
| 2023 Q4 | 265.56 Million CNY | -13.93% |
| 2022 Q4 | 213.56 Million CNY | -17.29% |
| 2022 Q3 | 258.19 Million CNY | 1.86% |
| 2022 Q2 | 253.48 Million CNY | -0.59% |
| 2022 Q1 | 255 Million CNY | 19.59% |
| 2022 FY | 213.56 Million CNY | 0.16% |
| 2021 Q1 | 218.62 Million CNY | 17.55% |
| 2021 Q4 | 213.22 Million CNY | 11.34% |
| 2021 FY | 213.22 Million CNY | 14.64% |
| 2021 Q2 | 189.5 Million CNY | -13.32% |
| 2021 Q3 | 191.5 Million CNY | 1.05% |
| 2020 Q2 | 173.01 Million CNY | -15.87% |
| 2020 Q4 | 185.99 Million CNY | 3.6% |
| 2020 FY | 185.99 Million CNY | 23.27% |
| 2020 Q3 | 179.52 Million CNY | 3.76% |
| 2020 Q1 | 205.65 Million CNY | 36.31% |
| 2019 Q2 | 186.39 Million CNY | 0.0% |
| 2019 FY | 150.87 Million CNY | -10.66% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 150.87 Million CNY | 0.0% |
| 2018 FY | 168.87 Million CNY | 45.23% |
| 2017 FY | 116.28 Million CNY | 41.91% |
| 2016 FY | 81.93 Million CNY | 0.0% |